Tevogen Bio Holdings Inc (TVGN) is not a good buy for a beginner investor with a long-term strategy at this time. The stock is facing negative sentiment due to a recent reverse stock split, weak financial performance, and lack of positive catalysts. Additionally, there are no strong trading signals or significant institutional or insider activity to support a buy decision.
The MACD is positive but contracting, RSI is neutral at 73.339, and moving averages are converging, indicating no clear trend. The stock is trading near its resistance level (R1: 6.54) in pre-market, with a pre-market price of 6.22, down 2.20%.
NULL identified. There are no recent news or events driving positive sentiment for the stock.
The recent 50:1 reverse stock split is perceived negatively by the market, and analysts expect additional near-term trading pressure. Financial performance is weak, with significant YoY declines in net income (-48.80%) and EPS (-46.71%).
In Q4 2025, revenue remained at 0 with no growth. Net income dropped to -4,817,717 (-48.80% YoY), and EPS fell to -2.35 (-46.71% YoY). Gross margin remained at 0 with no improvement.
D. Boral Capital downgraded the stock to Hold from Buy, citing the negative implications of the reverse stock split and weaker capital markets position.